Carboplatinum BM (Carboplatin-BM)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceCarboplatinCarboplatin
Similar drugsTo uncover
  • Carboplatin
    solution in / in 
    BIOCAD, CJSC     Russia
  • Carboplatinum BM
    concentrate d / infusion 
    PARIAL, LLC     Russia
  • Carboplatin-LENS®
    concentrate in / in d / infusion 
    LENS-PHARM, LLC     Russia
  • Carboplatin-RONTS®
    solution in / in 
    RNTS named after N.N. Blokhin RAMS     Russia
  • Carboplatin-Teva
    lyophilizate d / infusion 
    Teva Pharmaceutical Enterprises Co., Ltd.     Israel
  • Carboplatin-Ebene
    solution in / in 
    Ebewe Pharma Gesmb.b. Nfg. KG     Austria
  • Carbothers
    lyophilizate d / infusion 
    Laboratory Tutor SAASIFAA     Argentina
  • Kemokarb
    concentrate d / infusion 
    Fresenius Kabi Deutschland GmbH     Germany
  • Paract
    solution in / in 
    Actavis PTS ehf Group     Iceland
  • Cycloplatin
    concentrate d / infusion 
    Pliva-Lahema, AO     Czech Republic
    • Dosage form: & nbspconcentrate for solution for infusion
    Pharmacotherapeutic group:antitumor agent, alkylating compound
    ATX: & nbsp

    L.01.X.A.02   Carboplatin

    Form release / dosage:Concentrate for the preparation of solution for infusion, 10 mg / ml.
    Packaging:For 1 bottle in a cardboard box with instructions for the use of the drug.
    Shelf life:3 years.
    Terms of leave from pharmacies:On prescription
    Registration number:LP-001878
    Date of registration:11.10.2012
    The owner of the registration certificate:PARIAL, LLC PARIAL, LLC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp11.10.2012
    Illustrated instructions
      Instructions
      Up